Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Detalles Bibliográficos
Autores principales: Foss, Francine, Horwitz, Steven, Pro, Barbara, Miles Prince, H., Sokol, Lubomir, Balser, Barbara, Wolfson, Julie, Coiffier, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603163/
https://www.ncbi.nlm.nih.gov/pubmed/28923081
http://dx.doi.org/10.1186/s13045-017-0518-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603163/
https://www.ncbi.nlm.nih.gov/pubmed/28923081
http://dx.doi.org/10.1186/s13045-017-0518-8

Ejemplares similares